News | May 19, 2026
Lupin debuts in Dow Jones best-in-class indices for ESG performance
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The rating on senior secured notes issued by Biocon Biologics Global PLC was also upgraded to ‘BB+.’
Delivers robust earnings performance, successfully navigating a dynamic environment
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The company has played an important role in the procurement and distribution of emergency medical supplies supporting the Union Health Ministry for Covid–19 pandemic management
Subscribe To Our Newsletter & Stay Updated
